EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The PERK signaling pathway as a marker of the unfolded protein response in patients with acute myeloid leukemia

Nergiz Erkut iD, Turhan Köksal iD, Selim Demir iD, Ahmet Menteşe iD, Özlen Balta iD, Mehmet Sönmez iD

Turkish Journal of Medical Sciences · 12.02.2026 · 56 (1) · 344-350

DOI: 10.55730/1300-0144.6168 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Turkish Journal of Medical Sciences, online erschienen am 12.02.2026. Verfasst von Nergiz Erkut und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Hematology, Department of Internal Medicine, Faculty of Medicine, Karadeniz Technical University, Trabzon, Turkiye. Hauptthemen laut MEDLINE: Leukemia, Myeloid, Acute, eIF-2 Kinase, Unfolded Protein Response, Signal Transduction. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/aim: The protein kinase RNA-like endoplasmic reticulum kinase (PERK) pathway plays a critical role in preventing the accumulation of misfolded or unfolded proteins within the endoplasmic reticulum. In this study, the role of the PERK signaling pathway was evaluated in newly diagnosed, treatment-naïve patients with acute myeloid leukemia (AML). Materials and methods: Plasma levels of eukaryotic translation initiation factor 2-alpha kinase 3 (eIF2AK3), glucose-regulated protein 78 (GRP78), activating transcription factor 6 (ATF6), CCAAT/enhancer-binding protein homologous protein (CHOP), hypoxia-inducible factor-1 alpha (HIF-1α), and caspase 3 were measured by enzyme-linked immunosorbent assay in peripheral blood samples obtained from AML patients and healthy controls. Results: A total of 40 individuals were included, comprising 19 (47%) AML patients and 21 (53%) healthy controls. HIF-1α, eIF2AK3, GRP78, ATF6, CHOP, and caspase 3 levels were significantly higher in the AML group than in the control group (p = 0.019, 0.005,

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Leukemia, Myeloid, AcuteeIF-2 KinaseUnfolded Protein ResponseSignal TransductionHumansEndoplasmic Reticulum Chaperone BiPFemaleMaleAdultMiddle AgedActivating Transcription Factor 6Transcription Factor CHOPHeat-Shock Proteins

Stichwörter der Autor:innen

ATF6 signaling pathwayEndoplasmic reticulum stressPERK signaling pathwayapoptosishypoxia

Substanzen

HSPA5 protein, humanEndoplasmic Reticulum Chaperone BiPeIF-2 KinaseEIF2AK3 protein, humanActivating Transcription Factor 6ATF6 protein, humanTranscription Factor CHOPHeat-Shock Proteins

Autor:innen und Institutionen

  • Division of Hematology, Department of Internal Medicine, Faculty of Medicine, Karadeniz Technical University, Trabzon, Turkiye.
  • Division of Nutrition and Dietetics, Faculty of Health Sciences, Karadeniz Technical University, Trabzon, Turkiye.
  • Division of Medical Biochemistry, Faculty of Medicine, Karadeniz Technical University, Trabzon, Turkiye.

ORCID-Profile: Nergiz Erkut, Turhan Köksal, Selim Demir, Ahmet Menteşe, Özlen Balta, Mehmet Sönmez

Zitieren

APA

Erkut, N., Köksal, T., Demir, S., Menteşe, A., Balta, Ö., & Sönmez, M. (2026). The PERK signaling pathway as a marker of the unfolded protein response in patients with acute myeloid leukemia. Turkish Journal of Medical Sciences, 56(1), 344-350. https://doi.org/10.55730/1300-0144.6168

Vancouver

Erkut N, Köksal T, Demir S, Menteşe A, Balta Ö, Sönmez M. The PERK signaling pathway as a marker of the unfolded protein response in patients with acute myeloid leukemia. Turkish Journal of Medical Sciences. 2026;56(1):344-350. doi:10.55730/1300-0144.6168

BibTeX
@article{Erkut2026,
  author = {Erkut, Nergiz and Köksal, Turhan and Demir, Selim and Menteşe, Ahmet and Balta, Özlen and Sönmez, Mehmet},
  title = {The PERK signaling pathway as a marker of the unfolded protein response in patients with acute myeloid leukemia},
  journal = {Turkish Journal of Medical Sciences},
  year = {2026},
  volume = {56},
  number = {1},
  pages = {344--350},
  doi = {10.55730/1300-0144.6168}
}
Kostenlos starten →